According to Latest Study, the global market for Ds DNA Bacteriophage should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Ds DNA Bacteriophage market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Ds DNA Bacteriophage market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Animal Health grew percent to account for percent of the total market sales, and Aquaculture grew percent.
Bacteriophage (phage) is the general name of viruses that infect bacteria, fungi, algae, actinomycetes or spirochetes and other microorganisms. It is called bacteriophage because it can partially cause the lysis of host bacteria, and can be widely used in various fields of human life.
This report studies and analyses global Ds DNA Bacteriophage status and future trends, to help determine the Ds DNA Bacteriophage market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Ds DNA Bacteriophage, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Ds DNA Bacteriophage market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Ds DNA Bacteriophage by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Ds DNA Bacteriophage by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Ds DNA Bacteriophage key consuming regions, consumption value and demand structure
(5) Ds DNA Bacteriophage industry chains, upstream, midstream and downstream
Market segment by players, this report covers
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences, Inc
Pharmex Group, LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Market segment by Type, covers
Tail Structure Bacteriophage
Tailless Structure Bacteriophage
Market segment by Application, can be divided into
Animal Health
Aquaculture
Agriculture
Food lndustry
Human Health
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Ds DNA Bacteriophage product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Ds DNA Bacteriophage market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Ds DNA Bacteriophage market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Ds DNA Bacteriophage industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Ds DNA Bacteriophage Definition
1.2 Global Ds DNA Bacteriophage Market Size and Forecast
1.3 China Ds DNA Bacteriophage Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Ds DNA Bacteriophage Market Size: China VS Global Growth Rate, 2018-2029
1.6 Ds DNA Bacteriophage Market Dynamics
1.6.1 Ds DNA Bacteriophage Market Drivers
1.6.2 Ds DNA Bacteriophage Market Restraints
1.6.3 Ds DNA Bacteriophage Industry Trends
1.6.4 Ds DNA Bacteriophage Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Ds DNA Bacteriophage, Global Market Share by Company, 2018-2023
2.2 Global Ds DNA Bacteriophage Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Ds DNA Bacteriophage Concentration Ratio
2.4 Global Ds DNA Bacteriophage Mergers & Acquisitions, Expansion Plans
2.5 Global Ds DNA Bacteriophage Major Companies Product Type
2.6 Head Office and Ds DNA Bacteriophage Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Ds DNA Bacteriophage, China Market Share by Company, 2018-2023
3.2 China Ds DNA Bacteriophage Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Ds DNA Bacteriophage Industry Chain
4.2 Ds DNA Bacteriophage Upstream Analysis
4.2.1 Ds DNA Bacteriophage Core Raw Materials
4.2.2 Main Manufacturers of Ds DNA Bacteriophage Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Ds DNA Bacteriophage Production Mode
4.6 Ds DNA Bacteriophage Procurement Model
4.7 Ds DNA Bacteriophage Industry Sales Model and Sales Channels
4.7.1 Ds DNA Bacteriophage Sales Model
4.7.2 Ds DNA Bacteriophage Typical Distributors
5 Sights by Type
5.1 Ds DNA Bacteriophage Classification
5.1.1 Tail Structure Bacteriophage
5.1.2 Tailless Structure Bacteriophage
5.2 By Type, Global Ds DNA Bacteriophage Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Ds DNA Bacteriophage Consumption Value, 2018-2029
6 Sights by Application
6.1 Ds DNA Bacteriophage Segment by Application
6.1.1 Animal Health
6.1.2 Aquaculture
6.1.3 Agriculture
6.1.4 Food lndustry
6.1.5 Human Health
6.1.6 Others
6.2 By Application, Global Ds DNA Bacteriophage Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Ds DNA Bacteriophage Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Ds DNA Bacteriophage Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Ds DNA Bacteriophage Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Ds DNA Bacteriophage & Forecasts, 2018-2029
7.3.2 By Country, North America Ds DNA Bacteriophage Market Size Market Share
7.4 Europe
7.4.1 Europe Ds DNA Bacteriophage Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Ds DNA Bacteriophage Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Ds DNA Bacteriophage Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Ds DNA Bacteriophage Market Size Market Share
7.6 South America
7.6.1 South America Ds DNA Bacteriophage Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Ds DNA Bacteriophage Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Ds DNA Bacteriophage Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Ds DNA Bacteriophage Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Ds DNA Bacteriophage Market Size, 2018-2029
8.3.2 By Type, U.S. Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Ds DNA Bacteriophage Market Size, 2018-2029
8.4.2 By Type, Europe Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Ds DNA Bacteriophage Market Size, 2018-2029
8.5.2 By Type, China Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Ds DNA Bacteriophage Market Size, 2018-2029
8.6.2 By Type, Japan Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Ds DNA Bacteriophage Market Size, 2018-2029
8.7.2 By Type, South Korea Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Ds DNA Bacteriophage Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Ds DNA Bacteriophage Market Size, 2018-2029
8.9.2 By Type, India Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Ds DNA Bacteriophage Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 NPO Microgen
9.1.1 NPO Microgen Company Information, Head Office, Market Area and Industry Position
9.1.2 NPO Microgen Company Profile and Main Business
9.1.3 NPO Microgen Ds DNA Bacteriophage Models, Specifications and Application
9.1.4 NPO Microgen Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.1.5 NPO Microgen Recent Developments
9.2 Proteon Pharmaceuticals
9.2.1 Proteon Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.2.2 Proteon Pharmaceuticals Company Profile and Main Business
9.2.3 Proteon Pharmaceuticals Ds DNA Bacteriophage Models, Specifications and Application
9.2.4 Proteon Pharmaceuticals Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.2.5 Proteon Pharmaceuticals Recent Developments
9.3 Phagelux
9.3.1 Phagelux Company Information, Head Office, Market Area and Industry Position
9.3.2 Phagelux Company Profile and Main Business
9.3.3 Phagelux Ds DNA Bacteriophage Models, Specifications and Application
9.3.4 Phagelux Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.3.5 Phagelux Recent Developments
9.4 Intralytix
9.4.1 Intralytix Company Information, Head Office, Market Area and Industry Position
9.4.2 Intralytix Company Profile and Main Business
9.4.3 Intralytix Ds DNA Bacteriophage Models, Specifications and Application
9.4.4 Intralytix Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.4.5 Intralytix Recent Developments
9.5 Micreos
9.5.1 Micreos Company Information, Head Office, Market Area and Industry Position
9.5.2 Micreos Company Profile and Main Business
9.5.3 Micreos Ds DNA Bacteriophage Models, Specifications and Application
9.5.4 Micreos Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.5.5 Micreos Recent Developments
9.6 Eliava BioPreparations
9.6.1 Eliava BioPreparations Company Information, Head Office, Market Area and Industry Position
9.6.2 Eliava BioPreparations Company Profile and Main Business
9.6.3 Eliava BioPreparations Ds DNA Bacteriophage Models, Specifications and Application
9.6.4 Eliava BioPreparations Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.6.5 Eliava BioPreparations Recent Developments
9.7 Locus Biosciences, Inc
9.7.1 Locus Biosciences, Inc Company Information, Head Office, Market Area and Industry Position
9.7.2 Locus Biosciences, Inc Company Profile and Main Business
9.7.3 Locus Biosciences, Inc Ds DNA Bacteriophage Models, Specifications and Application
9.7.4 Locus Biosciences, Inc Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.7.5 Locus Biosciences, Inc Recent Developments
9.8 Pharmex Group, LLC
9.8.1 Pharmex Group, LLC Company Information, Head Office, Market Area and Industry Position
9.8.2 Pharmex Group, LLC Company Profile and Main Business
9.8.3 Pharmex Group, LLC Ds DNA Bacteriophage Models, Specifications and Application
9.8.4 Pharmex Group, LLC Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.8.5 Pharmex Group, LLC Recent Developments
9.9 Pherecydes Pharma
9.9.1 Pherecydes Pharma Company Information, Head Office, Market Area and Industry Position
9.9.2 Pherecydes Pharma Company Profile and Main Business
9.9.3 Pherecydes Pharma Ds DNA Bacteriophage Models, Specifications and Application
9.9.4 Pherecydes Pharma Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.9.5 Pherecydes Pharma Recent Developments
9.10 APS Biocontrol Ltd. (APS)
9.10.1 APS Biocontrol Ltd. (APS) Company Information, Head Office, Market Area and Industry Position
9.10.2 APS Biocontrol Ltd. (APS) Company Profile and Main Business
9.10.3 APS Biocontrol Ltd. (APS) Ds DNA Bacteriophage Models, Specifications and Application
9.10.4 APS Biocontrol Ltd. (APS) Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.10.5 APS Biocontrol Ltd. (APS) Recent Developments
9.11 Qingdao Phagepharm Bio-tech
9.11.1 Qingdao Phagepharm Bio-tech Company Information, Head Office, Market Area and Industry Position
9.11.2 Qingdao Phagepharm Bio-tech Company Profile and Main Business
9.11.3 Qingdao Phagepharm Bio-tech Ds DNA Bacteriophage Models, Specifications and Application
9.11.4 Qingdao Phagepharm Bio-tech Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.11.5 Qingdao Phagepharm Bio-tech Recent Developments
9.12 Fixed-Phage Limited
9.12.1 Fixed-Phage Limited Company Information, Head Office, Market Area and Industry Position
9.12.2 Fixed-Phage Limited Company Profile and Main Business
9.12.3 Fixed-Phage Limited Ds DNA Bacteriophage Models, Specifications and Application
9.12.4 Fixed-Phage Limited Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.12.5 Fixed-Phage Limited Recent Developments
9.13 Zeptometrix
9.13.1 Zeptometrix Company Information, Head Office, Market Area and Industry Position
9.13.2 Zeptometrix Company Profile and Main Business
9.13.3 Zeptometrix Ds DNA Bacteriophage Models, Specifications and Application
9.13.4 Zeptometrix Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.13.5 Zeptometrix Recent Developments
9.14 Phage International, Inc.
9.14.1 Phage International, Inc. Company Information, Head Office, Market Area and Industry Position
9.14.2 Phage International, Inc. Company Profile and Main Business
9.14.3 Phage International, Inc. Ds DNA Bacteriophage Models, Specifications and Application
9.14.4 Phage International, Inc. Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.14.5 Phage International, Inc. Recent Developments
9.15 MicroMir
9.15.1 MicroMir Company Information, Head Office, Market Area and Industry Position
9.15.2 MicroMir Company Profile and Main Business
9.15.3 MicroMir Ds DNA Bacteriophage Models, Specifications and Application
9.15.4 MicroMir Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.15.5 MicroMir Recent Developments
9.16 iNtODEWORLD, Inc.
9.16.1 iNtODEWORLD, Inc. Company Information, Head Office, Market Area and Industry Position
9.16.2 iNtODEWORLD, Inc. Company Profile and Main Business
9.16.3 iNtODEWORLD, Inc. Ds DNA Bacteriophage Models, Specifications and Application
9.16.4 iNtODEWORLD, Inc. Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.16.5 iNtODEWORLD, Inc. Recent Developments
9.17 NEXTBIOTICS
9.17.1 NEXTBIOTICS Company Information, Head Office, Market Area and Industry Position
9.17.2 NEXTBIOTICS Company Profile and Main Business
9.17.3 NEXTBIOTICS Ds DNA Bacteriophage Models, Specifications and Application
9.17.4 NEXTBIOTICS Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.17.5 NEXTBIOTICS Recent Developments
9.18 Armata Pharmaceuticals, Inc.
9.18.1 Armata Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position
9.18.2 Armata Pharmaceuticals, Inc. Company Profile and Main Business
9.18.3 Armata Pharmaceuticals, Inc. Ds DNA Bacteriophage Models, Specifications and Application
9.18.4 Armata Pharmaceuticals, Inc. Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.18.5 Armata Pharmaceuticals, Inc. Recent Developments
9.19 Innophage
9.19.1 Innophage Company Information, Head Office, Market Area and Industry Position
9.19.2 Innophage Company Profile and Main Business
9.19.3 Innophage Ds DNA Bacteriophage Models, Specifications and Application
9.19.4 Innophage Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.19.5 Innophage Recent Developments
9.20 Adaptive Phage Therapeutics
9.20.1 Adaptive Phage Therapeutics Company Information, Head Office, Market Area and Industry Position
9.20.2 Adaptive Phage Therapeutics Company Profile and Main Business
9.20.3 Adaptive Phage Therapeutics Ds DNA Bacteriophage Models, Specifications and Application
9.20.4 Adaptive Phage Therapeutics Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.20.5 Adaptive Phage Therapeutics Recent Developments
9.21 TechnoPhage
9.21.1 TechnoPhage Company Information, Head Office, Market Area and Industry Position
9.21.2 TechnoPhage Company Profile and Main Business
9.21.3 TechnoPhage Ds DNA Bacteriophage Models, Specifications and Application
9.21.4 TechnoPhage Ds DNA Bacteriophage Revenue and Gross Margin, 2018-2023
9.21.5 TechnoPhage Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Ds DNA Bacteriophage Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Ds DNA Bacteriophage Market Restraints
Table 3. Ds DNA Bacteriophage Market Trends
Table 4. Ds DNA Bacteriophage Industry Policy
Table 5. Global Ds DNA Bacteriophage Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Ds DNA Bacteriophage Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Ds DNA Bacteriophage Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Ds DNA Bacteriophage Mergers & Acquisitions, Expansion Plans
Table 9. Global Ds DNA Bacteriophage Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Ds DNA Bacteriophage Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Ds DNA Bacteriophage Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Ds DNA Bacteriophage Upstream (Raw Materials)
Table 14. Global Ds DNA Bacteriophage Typical Customers
Table 15. Ds DNA Bacteriophage Typical Distributors
Table 16. By Type, Global Ds DNA Bacteriophage Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Ds DNA Bacteriophage Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Ds DNA Bacteriophage Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Ds DNA Bacteriophage Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Ds DNA Bacteriophage Consumption Value Market Share, 2018-2029
Table 23. NPO Microgen Company Information, Head Office, Market Area and Industry Position
Table 24. NPO Microgen Company Profile and Main Business
Table 25. NPO Microgen Ds DNA Bacteriophage Models, Specifications, and Application
Table 26. NPO Microgen Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. NPO Microgen Recent Developments
Table 28. Proteon Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 29. Proteon Pharmaceuticals Company Profile and Main Business
Table 30. Proteon Pharmaceuticals Ds DNA Bacteriophage Models, Specifications, and Application
Table 31. Proteon Pharmaceuticals Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Proteon Pharmaceuticals Recent Developments
Table 33. Phagelux Company Information, Head Office, Market Area and Industry Position
Table 34. Phagelux Company Profile and Main Business
Table 35. Phagelux Ds DNA Bacteriophage Models, Specifications, and Application
Table 36. Phagelux Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Phagelux Recent Developments
Table 38. Intralytix Company Information, Head Office, Market Area and Industry Position
Table 39. Intralytix Company Profile and Main Business
Table 40. Intralytix Ds DNA Bacteriophage Models, Specifications, and Application
Table 41. Intralytix Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Intralytix Recent Developments
Table 43. Micreos Company Information, Head Office, Market Area and Industry Position
Table 44. Micreos Company Profile and Main Business
Table 45. Micreos Ds DNA Bacteriophage Models, Specifications, and Application
Table 46. Micreos Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Micreos Recent Developments
Table 48. Eliava BioPreparations Company Information, Head Office, Market Area and Industry Position
Table 49. Eliava BioPreparations Company Profile and Main Business
Table 50. Eliava BioPreparations Ds DNA Bacteriophage Models, Specifications, and Application
Table 51. Eliava BioPreparations Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Eliava BioPreparations Recent Developments
Table 53. Locus Biosciences, Inc Company Information, Head Office, Market Area and Industry Position
Table 54. Locus Biosciences, Inc Company Profile and Main Business
Table 55. Locus Biosciences, Inc Ds DNA Bacteriophage Models, Specifications, and Application
Table 56. Locus Biosciences, Inc Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Locus Biosciences, Inc Recent Developments
Table 58. Pharmex Group, LLC Company Information, Head Office, Market Area and Industry Position
Table 59. Pharmex Group, LLC Company Profile and Main Business
Table 60. Pharmex Group, LLC Ds DNA Bacteriophage Models, Specifications, and Application
Table 61. Pharmex Group, LLC Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Pharmex Group, LLC Recent Developments
Table 63. Pherecydes Pharma Company Information, Head Office, Market Area and Industry Position
Table 64. Pherecydes Pharma Company Profile and Main Business
Table 65. Pherecydes Pharma Ds DNA Bacteriophage Models, Specifications, and Application
Table 66. Pherecydes Pharma Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Pherecydes Pharma Recent Developments
Table 68. APS Biocontrol Ltd. (APS) Company Information, Head Office, Market Area and Industry Position
Table 69. APS Biocontrol Ltd. (APS) Company Profile and Main Business
Table 70. APS Biocontrol Ltd. (APS) Ds DNA Bacteriophage Models, Specifications, and Application
Table 71. APS Biocontrol Ltd. (APS) Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. APS Biocontrol Ltd. (APS) Recent Developments
Table 73. Qingdao Phagepharm Bio-tech Company Information, Head Office, Market Area and Industry Position
Table 74. Qingdao Phagepharm Bio-tech Company Profile and Main Business
Table 75. Qingdao Phagepharm Bio-tech Ds DNA Bacteriophage Models, Specifications, and Application
Table 76. Qingdao Phagepharm Bio-tech Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Qingdao Phagepharm Bio-tech Recent Developments
Table 78. Fixed-Phage Limited Company Information, Head Office, Market Area and Industry Position
Table 79. Fixed-Phage Limited Company Profile and Main Business
Table 80. Fixed-Phage Limited Ds DNA Bacteriophage Models, Specifications, and Application
Table 81. Fixed-Phage Limited Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. Fixed-Phage Limited Recent Developments
Table 83. Zeptometrix Company Information, Head Office, Market Area and Industry Position
Table 84. Zeptometrix Company Profile and Main Business
Table 85. Zeptometrix Ds DNA Bacteriophage Models, Specifications, and Application
Table 86. Zeptometrix Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 87. Zeptometrix Recent Developments
Table 88. Phage International, Inc. Company Information, Head Office, Market Area and Industry Position
Table 89. Phage International, Inc. Company Profile and Main Business
Table 90. Phage International, Inc. Ds DNA Bacteriophage Models, Specifications, and Application
Table 91. Phage International, Inc. Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 92. Phage International, Inc. Recent Developments
Table 93. MicroMir Company Information, Head Office, Market Area and Industry Position
Table 94. MicroMir Company Profile and Main Business
Table 95. MicroMir Ds DNA Bacteriophage Models, Specifications, and Application
Table 96. MicroMir Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 97. MicroMir Recent Developments
Table 98. iNtODEWORLD, Inc. Company Information, Head Office, Market Area and Industry Position
Table 99. iNtODEWORLD, Inc. Company Profile and Main Business
Table 100. iNtODEWORLD, Inc. Ds DNA Bacteriophage Models, Specifications, and Application
Table 101. iNtODEWORLD, Inc. Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 102. iNtODEWORLD, Inc. Recent Developments
Table 103. NEXTBIOTICS Company Information, Head Office, Market Area and Industry Position
Table 104. NEXTBIOTICS Company Profile and Main Business
Table 105. NEXTBIOTICS Ds DNA Bacteriophage Models, Specifications, and Application
Table 106. NEXTBIOTICS Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 107. NEXTBIOTICS Recent Developments
Table 108. Armata Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position
Table 109. Armata Pharmaceuticals, Inc. Company Profile and Main Business
Table 110. Armata Pharmaceuticals, Inc. Ds DNA Bacteriophage Models, Specifications, and Application
Table 111. Armata Pharmaceuticals, Inc. Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 112. Armata Pharmaceuticals, Inc. Recent Developments
Table 113. Innophage Company Information, Head Office, Market Area and Industry Position
Table 114. Innophage Company Profile and Main Business
Table 115. Innophage Ds DNA Bacteriophage Models, Specifications, and Application
Table 116. Innophage Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 117. Innophage Recent Developments
Table 118. Adaptive Phage Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 119. Adaptive Phage Therapeutics Company Profile and Main Business
Table 120. Adaptive Phage Therapeutics Ds DNA Bacteriophage Models, Specifications, and Application
Table 121. Adaptive Phage Therapeutics Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 122. Adaptive Phage Therapeutics Recent Developments
Table 123. TechnoPhage Ds DNA Bacteriophage Company Information, Head Office, Market Area and Industry Position
Table 124. TechnoPhage Company Profile and Main Business
Table 125. TechnoPhage Ds DNA Bacteriophage Models, Specifications, and Application
Table 126. TechnoPhage Ds DNA Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 127. TechnoPhage Recent Developments
List of Figures
Figure 1. Ds DNA Bacteriophage Picture
Figure 2. Global Ds DNA Bacteriophage Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Ds DNA Bacteriophage Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Ds DNA Bacteriophage Market Share of Global, 2018-2029
Figure 5. Global Ds DNA Bacteriophage Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Ds DNA Bacteriophage Key Participants, Market Share, 2022
Figure 7. Ds DNA Bacteriophage Industry Chain
Figure 8. Ds DNA Bacteriophage Procurement Model
Figure 9. Ds DNA Bacteriophage Sales Model
Figure 10. Ds DNA Bacteriophage Sales Channels, Direct Sales, and Distribution
Figure 11. Tail Structure Bacteriophage
Figure 12. Tailless Structure Bacteriophage
Figure 13. By Type, Global Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 14. By Type, Global Ds DNA Bacteriophage Consumption Value Market Share, 2018-2029
Figure 15. Animal Health
Figure 16. Aquaculture
Figure 17. Agriculture
Figure 18. Food lndustry
Figure 19. Human Health
Figure 20. Others
Figure 21. By Application, Global Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 22. By Application, Global Ds DNA Bacteriophage Consumption Value Market Share, 2018-2029
Figure 23. By Region, Global Ds DNA Bacteriophage Consumption Value Market Share, 2018-2029
Figure 24. North America Ds DNA Bacteriophage Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, North America Ds DNA Bacteriophage Consumption Value Market Share, 2022
Figure 26. Europe Ds DNA Bacteriophage Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, Europe Ds DNA Bacteriophage Consumption Value Market Share, 2022
Figure 28. Asia Pacific Ds DNA Bacteriophage Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country/Region, Asia Pacific Ds DNA Bacteriophage Consumption Value Market Share, 2022
Figure 30. South America Ds DNA Bacteriophage Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. By Country, South America Ds DNA Bacteriophage Consumption Value Market Share, 2022
Figure 32. Middle East & Africa Ds DNA Bacteriophage Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 33. U.S. Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 34. By Type, U.S. Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 35. By Application, U.S. Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 36. Europe Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 37. By Type, Europe Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 38. By Application, Europe Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 39. China Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 40. By Type, China Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 41. By Application, China Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 42. Japan Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 43. By Type, Japan Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 44. By Application, Japan Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 45. South Korea Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 46. By Type, South Korea Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 47. By Application, South Korea Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 48. Southeast Asia Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 49. By Type, Southeast Asia Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 50. By Application, Southeast Asia Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 51. India Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 52. By Type, India Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 53. By Application, India Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 54. Middle East & Africa Ds DNA Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 55. By Type, Middle East & Africa Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 56. By Application, Middle East & Africa Ds DNA Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 57. Research Methodology
Figure 58. Breakdown of Primary Interviews
Figure 59. Bottom-up and Top-down Approaches
Figure 60. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|